Skip to main content

Table 2 IgRh prophylaxis summary

From: Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Newborn phenotype RHD + RHD - ND Total
Genotyping arm
Number of patients 368 (100%) 136 (100%) 11 (100%) 515 (100%)
At least one injection 366 (99%) 24 (18%) 8 (73%) 397 (77%)
 prophylaxis 320 (87%) 10 (7%) 6 (55%) 336 (65%)
 obstetrical event 95 (26%) 16 (12%) 2 (18%) 113 (22%)
 postpartum 346 (94%) 1 (1%) 8 (73%) 354 (69%)
No injection 2 (1%) 112 (82%) 3 (27%) 118 (23%)
Control arm
Number of patients 212 (100%) 100 (100%) 23 (100%) 335 (100%)
At least one injection 211 (99.5%) 85 (85%) 19 (83%) 315 (94%)
 prophylaxis 174 (82%) 73 (73%) 14 (61%) 261 (78%)
 obstetrical event 50 (24%) 19 (19%) 5 (22%) 74 (22%)
 postpartum 198 (93%) 2 (2%) 4 (17%) 204 (61%)
No injection 1 (0.5%) 15 (15%) 4 (17%) 20 (6%)